Navigation Links
Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA

nd other filings with the SEC, including the "Risk Factors" sections of such reports.

Any forward-looking statements are made pursuant to Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and, as such, speak only as of the date made. Micromet and MedImmune undertake no obligation to publicly update any forward- looking statements, whether as a result of new information, future events or otherwise.

CONTACT: MedImmune: Investors, Peter Vozzo, Director, Investor Relations,+1-301-398-4358, or Media, Kate Barrett, Manager, Public Relations,+1-301-398-4320; or Micromet: Company, Chris Schnittker, SVP & CFO,+1-267-242-3151, ; or Investors,Susan Noonan, +1-212-966-3650, , or Media, Pat Garrison,+1-917-322-2567, christopher.schnittker@micromet-inc.com susan@sanoonan.com pgarrison@rxir.com

Web site: http://www.micromet-inc.com/http://www.medimmune.com/

Ticker Symbol: (NASDAQ-NMS:MITI),(NASDAQ-NMS:MEDI)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference
2. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
3. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
4. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
5. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
6. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
7. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
8. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
9. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
10. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
11. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR

Post Your Comments:
(Date:11/25/2009)...Netherlands and JOHANNESBURG, November 25 /PRNewsw...and Pyxis Discovery announced today,that they have...t both,companies, services. , Pyxis,s wor...y expertise,will be coupled with iThemba,s service...stry support to projects identified through Pyxis,...
(Date:11/25/2009)...f., Nov. 25 ChemoCentryx, Inc., ...om the Company,s PROTECT-1 (the Prospective Random...ial) of Traficet-EN(TM) (CCX282-B) in patients wit...clinical efficacy with a favorable safety and tole... of clinical efficacy in the reduction of disease ...
(Date:11/24/2009)...24 ,, WHAT: Rom Houbens, a Be...s following an auto accident, was actually fully c...bject of a Good Morning America segment. The Dyna...te how people with Locked-in Syndrome and other co...od Morning America -- Tuesday, November 24 avail...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2United Fresh to Feature Salad Bar at Capitol Hill Event to Advocate National School Salad Bar Policy 54927 1United Fresh to Feature Salad Bar at Capitol Hill Event to Advocate National School Salad Bar Policy 54927 2United Fresh to Feature Salad Bar at Capitol Hill Event to Advocate National School Salad Bar Policy 54927 3AMDL Inc Announces Second Quarter 2009 Financial Results 54924 1AMDL Inc Announces Second Quarter 2009 Financial Results 54924 2AMDL Inc Announces Second Quarter 2009 Financial Results 54924 3AMDL Inc Announces Second Quarter 2009 Financial Results 54924 4AMDL Inc Announces Second Quarter 2009 Financial Results 54924 5AMDL Inc Announces Second Quarter 2009 Financial Results 54924 6AMDL Inc Announces Second Quarter 2009 Financial Results 54924 7Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 1Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 2Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 3Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 4Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 5Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 6Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 7Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 8Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 9
...echnology has enabled more and more laboratory tes... the central laboratory is hardly threatened with ...um and large labs are busier than ever before, and...rd reliability and ability to handle very large vo... position in the clinical landscape. , ,This i...
...nza infections in this country cause more than 114...Among healthy adults, bronchitis and pneumonia are...a and pneumonia are the sixth leading cause of dea... dangerous in elderly and immunocompromised people...a strains are serious illnesses in any patient. Pr...
Other Medicine Technology:When Volume Matters, Immunoassay Systems Deliver 2When Volume Matters, Immunoassay Systems Deliver 3Fast, Accurate Influenza A/B Antigen Detection 2Fast, Accurate Influenza A/B Antigen Detection 3
(Date:11/28/2009)... Study finds gene variation believed to affect cir...(HealthDay News) -- New research suggests that an ...e a factor in the development of bipolar disorder ...amination of the genetic makeup of 152 children wi...ible to major mood swings, and 140 children withou...
(Date:11/27/2009)..., Biotech firm Replikins ...of the H1N1 virus genomic data. It shows that the...of 3.7 (s.d. 4.5) during the virus,s current outbr...levels this week of 2.0 (s.d. 0.1). The H1N1 infec... Boston (PRWEB) November 27, 200...
(Date:11/27/2009)..., , NEUILLY-SUR-SEINE, France, Nov. 27 ...American professional cycling team dedicated to et...of cycling champions, announced today that it will...of Transitions Optical as a new sponsor of the tea...facturer of adaptive eyewear, offering the most ad...
(Date:11/27/2009)... Soaring rates to bring unprecedented medical, eco..., Nov. 27 (HealthDay News) -- The number of people... double over the next 25 years, a new study predic...ut 44.1 million people with the disease, up from 2...t of treating people with diabetes will triple, th...
(Date:11/27/2009)..., Specialist manufacturer... products are saving millions of dollars by bringi...gn process. Increasing numbers of pro-active medic...experts at the concept stage of their projects, en...isting design processes or potentially outdated te...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...search Funding to Prevent Setbacks in the Fight Ag...rch 16 With thousands of Americans losing health ...warns lawmakers that recent progress in reducing t...n, American Heart Association leadership outlined ...
...s safe and effective against heart attack in men, ...thDay News) -- Amid the continuing debate over who...ease, and at what dose, U.S. experts have revised ... dosage has long been discussed because aspirin ca...
... us the nation is getting fatter, and that obesity...story, according to one University of Houston soci...been a shift in body weight over the years, assist...an says. And the use of the Body Mass Index, which...
...ISCO, Calif., March 16 Poniard Pharmaceuticals, I... focused on oncology, today announced that its aud...d December 31, 2008, included in the Company,s Ann...This announcement is required by Nasdaq Marketplac...
...ose monitoring offers some men better quality of l...-- Refusing immediate treatment can be safe for me... monitored, new research finds. , The multi-cente...n a challenging question that faces patients and u...
...er of Health Systems Operating Retail-Based Care ,...onvenient care clinics across the country steadily...tems are exploring this relatively new health care...ally for non-profit health systems. , , The goal ...
Other Medicine News:Health News:American Heart Association Urges Congress to Accelerate Efforts to Enact Comprehensive Health Care Reform 2Health News:American Heart Association Urges Congress to Accelerate Efforts to Enact Comprehensive Health Care Reform 3Health News:American Heart Association Urges Congress to Accelerate Efforts to Enact Comprehensive Health Care Reform 4Health News:Experts Revise Guidelines on Daily Aspirin for Heart 2Health News:Experts Revise Guidelines on Daily Aspirin for Heart 3Health News:UH sociologist has different perspective on obesity 'epidemic' 2Health News:UH sociologist has different perspective on obesity 'epidemic' 3Health News:Poniard Pharmaceuticals Receives Going Concern Qualification 2Health News:'Watchful Waiting' Safe With Low-Risk Prostate Cancers 2Health News:Convenient Care Association Forms Round-Table for Health Systems Operating Convenient Care Clinics 2
Low Contrast Flip Chart with Lea Symbols
HOTV Distance Acuity Chart BCDI
Symbol 10' Test Chart BCS10
Binkhorst Hooked Cannula
Medicine Products: